Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 16

1.

The minimum information required for a glycomics experiment (MIRAGE) project: improving the standards for reporting glycan microarray-based data.

Liu Y, McBride R, Stoll M, Palma AS, Silva L, Agravat S, Aoki-Kinoshita KF, Campbell MP, Costello CE, Dell A, Haslam SM, Karlsson NG, Khoo KH, Kolarich D, Novotny MV, Packer NH, Ranzinger R, Rapp E, Rudd PM, Struwe WB, Tiemeyer M, Wells L, York WS, Zaia J, Kettner C, Paulson JC, Feizi T, Smith DF.

Glycobiology. 2016 Nov 22. [Epub ahead of print]

2.

Macrophage-Targeting Gene Delivery Using a Micelle Composed of Mannose-Modified Lipid with Triazole Ring and Dioleoyl Trimethylammonium Propane.

Fukuda I, Mochizuki S, Sakurai K.

Biomed Res Int. 2015;2015:350580. doi: 10.1155/2015/350580. Epub 2015 Oct 5.

3.

Synthesis of α-L-rhamnosyl ceramide and evaluation of its binding with anti-rhamnose antibodies.

Long DE, Karmakar P, Wall KA, Sucheck SJ.

Bioorg Med Chem. 2014 Oct 1;22(19):5279-89. doi: 10.1016/j.bmc.2014.08.002. Epub 2014 Aug 12.

4.

Tumor-associated glycans and their role in gynecological cancers: accelerating translational research by novel high-throughput approaches.

Pochechueva T, Jacob F, Fedier A, Heinzelmann-Schwarz V.

Metabolites. 2012 Nov 14;2(4):913-39. doi: 10.3390/metabo2040913.

5.

Uncovering cryptic glycan markers in multiple sclerosis (MS) and experimental autoimmune encephalomyelitis (EAE).

Wang D, Bhat R, Sobel RA, Huang W, Wang LX, Olsson T, Steinman L.

Drug Dev Res. 2014 May;75(3):172-88. doi: 10.1002/ddr.21169. Epub 2014 Mar 11.

6.

Inflammatory bowel disease serology in Asia and the West.

Prideaux L, Kamm MA, De Cruz P, van Langenberg DR, Ng SC, Dotan I.

World J Gastroenterol. 2013 Oct 7;19(37):6207-13. doi: 10.3748/wjg.v19.i37.6207.

7.

High-throughput profiling of anti-glycan humoral responses to SIV vaccination and challenge.

Campbell CT, Llewellyn SR, Demberg T, Morgan IL, Robert-Guroff M, Gildersleeve JC.

PLoS One. 2013 Sep 23;8(9):e75302. doi: 10.1371/journal.pone.0075302. eCollection 2013. Erratum in: PLoS One. 2013;8(12). doi:10.1371/annotation/fd9f4a65-3f27-46cd-8ed0-6c9b8ba7f83b. Damberg, Thorsten [corrected to Demberg, Thorsten].

8.

Serum biomarker gMS-Classifier2: predicting conversion to clinically definite multiple sclerosis.

Arrambide G, Espejo C, Yarden J, Fire E, Spector L, Dotan N, Dukler A, Rovira A, Montalban X, Tintore M.

PLoS One. 2013;8(3):e59953. doi: 10.1371/journal.pone.0059953. Epub 2013 Mar 28.

9.

Predictive nature of IgM anti-α-glucose serum biomarker for relapse activity and EDSS progression in CIS patients: a BENEFIT study analysis.

Freedman MS, Metzig C, Kappos L, Polman CH, Edan G, Hartung HP, Miller DH, Montalban X, Yarden J, Spector L, Fire E, Dotan N, Schwenke S, Lanius V, Sandbrink R, Pohl C.

Mult Scler. 2012 Jul;18(7):966-73. doi: 10.1177/1352458511432327. Epub 2011 Dec 19.

10.

Glycan microarrays for decoding the glycome.

Rillahan CD, Paulson JC.

Annu Rev Biochem. 2011;80:797-823. doi: 10.1146/annurev-biochem-061809-152236. Review.

11.

Profiling human serum antibodies with a carbohydrate antigen microarray.

Oyelaran O, McShane LM, Dodd L, Gildersleeve JC.

J Proteome Res. 2009 Sep;8(9):4301-10. doi: 10.1021/pr900515y.

12.

Anti-alpha-glucose-based glycan IgM antibodies predict relapse activity in multiple sclerosis after the first neurological event.

Freedman MS, Laks J, Dotan N, Altstock RT, Dukler A, Sindic CJ.

Mult Scler. 2009 Apr;15(4):422-30. doi: 10.1177/1352458508101944.

13.

New serological biomarkers of inflammatory bowel disease.

Li X, Conklin L, Alex P.

World J Gastroenterol. 2008 Sep 7;14(33):5115-24. Review.

14.

Lipoteichoic acid synergizes with glycosphingolipids to potently stimulate secretion of interleukin-6 from human blood cells.

Meron-Sudai S, Matityahou A, Keisari Y, Cox KH, Hasty DL, Ofek I.

Clin Vaccine Immunol. 2008 Sep;15(9):1309-15. doi: 10.1128/CVI.00060-08. Epub 2008 Jul 16.

15.

Sugar Chips immobilized with synthetic sulfated disaccharides of heparin/heparan sulfate partial structure.

Wakao M, Saito A, Ohishi K, Kishimoto Y, Nishimura T, Sobel M, Suda Y.

Bioorg Med Chem Lett. 2008 Apr 1;18(7):2499-504. doi: 10.1016/j.bmcl.2008.01.069. Epub 2008 Jan 19.

16.

Printed covalent glycan array for ligand profiling of diverse glycan binding proteins.

Blixt O, Head S, Mondala T, Scanlan C, Huflejt ME, Alvarez R, Bryan MC, Fazio F, Calarese D, Stevens J, Razi N, Stevens DJ, Skehel JJ, van Die I, Burton DR, Wilson IA, Cummings R, Bovin N, Wong CH, Paulson JC.

Proc Natl Acad Sci U S A. 2004 Dec 7;101(49):17033-8. Epub 2004 Nov 24.

Supplemental Content

Support Center